Research and analysis

Global high consequence infectious disease events: summary August 2023

Updated 25 April 2024

Interpreting this report

The report provides updates on known, high-consequence infectious disease (HCID) events around the world as monitored by the UK Health Security Agency’s (UKHSA) epidemic intelligence activities.

The report is divided into 2 sections covering all the defined HCID pathogens. The first section contains contact and airborne HCIDs that have been specified for the HCID programme by NHS England. The second section contains additional HCIDs that are important for situational awareness.

Each section contains information on known pathogens and includes descriptions of recent events. If an undiagnosed disease event occurs that could be interpreted as a potential HCID, a third section will be added to the report.

Events found during routine scanning activities that occur in endemic areas will briefly be noted in the report. Active surveillance, other than daily epidemic intelligence activities, of events in endemic areas will not be conducted (for example, actively searching government websites or other sources for data on case numbers).

The target audience for this report is any healthcare professional who may be involved in HCID identification, treatment and management.

Risk rating

Included for each disease is a current risk rating based on the probability of introduction to the UK and potential impact. Past UK experience and the global occurrence of travel-associated cases are also considered. Currently, all diseases are classified into one of 3 categories: Low, Very low and Exceptionally low/negligible.

Incidents of significance of primary HCIDs

Contact HCIDs

Crimean-Congo haemorrhagic fever (CCHF)

Geographical risk areas	Endemic in Africa, the Balkans, the Middle East and western and south-central Asia. Cases have also been reported in Russia and Georgia. Spain has previously reported locally acquired cases (first reported in 2016, with the latest case reported in 2022).
Sources and routes of infection	• bite from, or crushing of, an infected tick • contact with the blood, tissues or body fluids of infected humans or animals
UK experience to date	Two cases have been reported in individuals who have travelled to the UK from Afghanistan in 2012 and Bulgaria in 2014
Risk rating	Low – rarely reported in travellers.
Recent cases or outbreaks	Between January and 26 August 2023, a total of 949 suspected CCHF cases, including 96 deaths (case fatality rate (CFR) of 10.1%) were reported in Afghanistan by the World Health Organization (WHO). Of 844 suspected cases tested since the beginning of 2023, 290 were confirmed. In 2022, Afghanistan reported 103 confirmed CCHF cases, including 15 deaths. On 2 August 2023, media reported one fatal case of CCHF in Gujarat State, India. In Iran, on 25 August 2023, media reported that health authorities had registered 60 cases of CCHF, including 3 deaths, since the beginning of the year. In Iraq, media reported on 31 August 2023 that 505 confirmed cases of CCHF, including 64 deaths had been reported nationally in 2023. Dhi Qar Governorate reported the most cases (125 cases, including 12 deaths), followed by Basra Governorate (76 cases, including 11 deaths). On 14 August 2023, media reported a confirmed case of CCHF in Shymkent, Kazakhstan, the first case of the year identified in this area. Between 30 July and 14 August 2023, 3 CCHF cases, including one death, were reported in the central part of North Macedonia. Two of the cases (including the fatality) were associated with tick bite exposures, while the third case was a healthcare worker who treated the fatal case. Prior to these cases, only one laboratory-confirmed case had been reported in the country (in 2010) since the first detection of CCHF in 1971.  In Pakistan, on 6 August 2023, media reported that 14 confirmed CCHF cases, including 4 deaths, had been identified in Khyber Pakhtunkhwa Province since the beginning of the year. On 22 August 2023, media also reported that 28 confirmed CCHF cases, including 9 deaths had been detected in Balochistan Province this year. In Russia, media reported on 7 August 2023 that 5 confirmed cases of CCHF had been registered since the start of the year in Rostov. On 22 August 2023, media reported that 6 cases of CCHF, including 3 deaths, had been reported in Senegal in 2023. In Turkey, on 5 August 2023, media reported one confirmed fatal case of CCHF in a female in Giresun Province.

Ebola virus disease (EVD)

Geographical risk areas	Map of countries which have reported EVD cases up to January 2023.
Sources and routes of infection	• contact with blood, tissues or body fluids of infected animals, or consumption of raw or undercooked infected animal tissue • contact with infected human blood or body fluids
UK experience to date	Four confirmed cases (one lab-acquired in the UK in 1976, 3 healthcare workers associated with West African epidemic 2014 to 2015).
Risk rating	Very low – other than during the West Africa outbreak, exported cases are extremely rare.
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Lassa fever

Geographical risk areas	Endemic in sub-Saharan West Africa.
Sources and routes of infection	• contact with excreta, or materials contaminated with excreta from an infected rodent • inhalation of aerosols of excreta from an infected rodent • contact with infected human blood or body fluids
UK experience to date	Three travel-related Lassa fever cases reported in 2022. Prior to this, 13 imported Lassa fever cases had been reported since 1971, all in travellers from West Africa.
Risk rating	Low – overall, Lassa fever is the most common imported viral haemorrhagic fever (VHF) but importations to the UK are still rare.
Recent cases or outbreaks	In Liberia, from 6 January 2022 to 23 August 2023, a total of 89 confirmed cases of Lassa fever and 24 deaths (CFR of 15.7%) were reported. Between January and 27 August 2023, Nigeria reported 1,053 confirmed, 9 probable and 7,079 suspected Lassa fever cases. Among confirmed cases, 181 deaths have been reported (CFR of 17.2%). The number of cases reported in 2023 is higher compared to the equivalent 2022 period (899 confirmed cases, including 174 deaths), while the CFR remains lower (19.4%).

Marburg virus disease (MVD)

Geographical risk areas	Sporadic outbreaks have previously been reported in Central and Eastern Africa. A human case of MVD was reported in August 2021 in Guinea; this was the first case to be identified in West Africa. MVD cases were reported in Ghana for the first time in July 2022. MVD outbreaks were reported for the first time in Equatorial Guinea in February 2023 and in Tanzania in March 2023.
Sources and routes of infection	• exposure in mines or caves inhabited by Rousettus bat colonies • contact with infected human blood or body fluids
UK experience to date	No reported cases in the UK.
Risk rating	Very low – globally, 5 travel-related exported MVD cases have previously been reported in the literature.
Recent cases or outbreaks	No confirmed or suspected human cases were reported in August 2023.

Airborne HCIDs

Avian influenza A(H7N9) virus

Geographical risk areas	All reported human infections have been acquired in China.
Sources and routes of infection	• close contact with infected birds or their environments • close contact with infected humans (no sustained human-to-human transmission)
UK experience to date	No known cases in the UK.
Risk rating	Very low (UKHSA risk assessment).
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Avian influenza A(H5N1) virus

Geographical risk areas	Human cases have been predominantly reported in South East Asia, but also in Egypt, Iraq, Pakistan, Turkey and Nigeria. Human cases (clade 2.3.4.4b) were reported in Spain and the USA in 2022, and in the UK in 2022 and 2023. The first human cases of avian influenza A(H5N1) (clade 2.3.4.4b) were reported from South America in 2023, from Ecuador and Chile.
Sources and routes of infection	• close contact with infected birds or their environments • close contact with infected humans (no sustained human-to-human transmission)
UK experience to date	As of August 2023, 5 detections were reported in the UK, one in 2022 and 4 in 2023.
Risk rating	Very low (UKHSA risk assessment).
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Middle East respiratory syndrome (MERS-CoV)

Geographical risk areas	The Arabian Peninsula – Yemen, Qatar, Oman, Bahrain, Kuwait, Saudi Arabia and United Arab Emirates.
Sources and routes of infection	• airborne particles • direct contact with contaminated environment • direct contact with camels or consumption of raw camel milk
UK experience to date	Five MERS-CoV cases in total – 3 imported cases (2012, 2013 and 2018), 2 secondary cases in close family members of the case in 2013, 3 deaths.
Risk rating	Very low (UKHSA risk assessment).
Recent cases or outbreaks	Between 13 September 2022 and 12 August 2023, the Ministry of Health of Saudi Arabia reported 3 confirmed cases of MERS-CoV, including 2 associated deaths. The cases were reported from Riyadh, Asser and Makkah regions. Of the 3 cases, 2 had a history of contact with dromedary camels and all 3 cases had a history of consumption of raw camel milk in the 14 days prior to symptom onset. Since 2012, a total of 2,196 cases, including 856 deaths (CFR of 39%) have been reported from Saudi Arabia.

Mpox (Clade I only)

Geographical risk areas	Central Africa including, Central African Republic, Cameroon, the Democratic Republic of the Congo (DRC), Gabon and Republic of the Congo.
Sources and routes of infection	• close contact with an infected animal (in an endemic country) or an infected person • contact with clothing or linens (such as bedding or towels) used by an infected person • direct contact with mpox skin lesions or scabs • coughing or sneezing of an individual with an mpox rash • consumption of contaminated bushmeat
UK experience to date	In June 2022, the Advisory Committee on Dangerous Pathogens (ACDP) recommended that the strain of monkeypox virus (MPXV) largely responsible for the global outbreak (Clade IIb, B.1 lineage) should no longer be classified as an HCID. In January 2023, the ACDP recommended that all Clade II MPXV should no longer be classified as an HCID. No cases of Clade I mpox have been reported in the UK. Between 2018 and 2021, 7 cases of mpox were identified in the UK which would no longer be classified as HCID mpox, but were treated as HCID cases at the time: 4 of the cases were imported from Nigeria, 2 cases were household contacts and one case was a healthcare worker involved in the care of an imported case.
Risk rating	Very low – no known importations of Clade I mpox into the UK.
Recent cases or outbreaks	Sequencing data is rarely available for mpox cases reported from endemic African countries where clade I MPXV is known to circulate. In August 2023, 46 new confirmed cases (no deaths) were reported from the Democratic Republic of the Congo, and 7 new confirmed cases (no deaths) were reported from the Republic of the Congo. These are the first cases reported by WHO from this country in 2023. This brings the total number of confirmed cases reported since the start of 2023 to 601, including 2 deaths.

Nipah virus

Geographical risk areas	South East Asia, predominantly in Bangladesh and India. Cases have also been reported in Malaysia and Singapore.
Sources and routes of infection	• direct or indirect exposure to infected bats • consumption of contaminated raw date palm sap • close contact with infected pigs or humans
UK experience to date	No known cases in the UK.
Risk rating	Exceptionally low/negligible – no travel-related infections in the literature.
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Pneumonic plague (Yersinia pestis)

Geographical risk areas	Predominantly sub-Saharan Africa but also Asia, North Africa, South America, Western USA. Endemic in Madagascar, Peru, and the DRC.
Sources and routes of infection	• flea bites • close contact with infected animals • close contact with human cases of pneumonic plague
UK experience to date	Last outbreak in the UK was in 1918.
Risk rating	Exceptionally low/negligible – no known current outbreaks globally.
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Severe acute respiratory syndrome (SARS)

Geographical risk areas	Currently none. Two historical outbreaks originating from China in 2002 and 2004.
Sources and routes of infection	• airborne particles • direct contact with contaminated environment
UK experience to date	Four imported SARS cases related to the 2002 outbreak.
Risk rating	Exceptionally low/negligible – no cases have been reported internationally since 2004.
Recent cases or outbreaks	No confirmed or suspected human cases reported globally since 2004.

Incidents of significance of additional HCIDs

Argentine haemorrhagic fever (Junin virus)

Geographical risk areas	Argentina (central). Endemic to the provinces of Buenos Aires, Córdoba, Santa Fe and La Pampa.
Sources and routes of infection	• direct contact with infected rodents • inhalation of infectious rodent fluids and excreta • person-to-person transmission has been documented
UK experience to date	No known cases in the UK.
Risk rating	Exceptionally low/negligible – one travel-related case was identified in Belgium in 2020.
Recent cases or outbreaks	On 2 August 2023, media reported one fatal case of Argentine haemorrhagic fever in a male aged 53 years in Buenos Aires, who is reported to have worked in a rural setting.

Bolivian haemorrhagic fever (Machupo virus)

Geographical risk areas	Bolivia – cases have been identified in the departments of Beni (Mamoré, Iténez and Yucuma provinces) and Cochabamba (Cercado province).
Sources and routes of infection	• direct contact with infected rodents • inhalation of infectious rodent fluids and excreta • person-to-person transmission has been documented
UK experience to date	No known cases in the UK.
Risk rating	Exceptionally low/negligible – travel-related cases have never been reported.
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Lujo virus disease

Geographical risk areas	A single case acquired in Zambia led to a cluster in South Africa in 2008.
Sources and routes of infection	• presumed rodent contact (excreta, or materials contaminated with excreta of infected rodent) • person to person via body fluids
UK experience to date	No known cases in the UK.
Risk rating	Exceptionally low/negligible – a single travel-related case has been reported. No cases have been reported anywhere since 2008.
Recent cases or outbreaks	No confirmed or suspected human cases reported since 2008.

Severe fever with thrombocytopenia syndrome (SFTS)

Geographical risk areas	Mainly reported from China (south-eastern), Japan and Korea. Cases have also been reported in Taiwan, Thailand, Myanmar and Vietnam. Serological evidence of SFTS in Pakistan.
Sources and routes of infection	• presumed to be tick exposure • person-to-person transmission described in household and hospital contacts, via contact with blood or bloodstained body fluids
UK experience to date	No known cases in the UK.
Risk rating	Exceptionally low/negligible – not known to have occurred in travellers.
Recent cases or outbreaks	On 8 August 2023, media reported that 6 cases of SFTS had been identified in 2023, up to 4 August, in South Chungcheong Province, South Korea. Two fatal cases of SFTS were reported in Japan during August 2023. The first case was reported by media on 9 August 2023 from Hiroshima Prefecture; this is the fifth case reported from this prefecture in 2023, and the first SFTS associated death. The second case was reported by media on 17 August 2023 from Fukuoka Prefecture; this is the second SFTS associated death reported from Fukuoka Prefecture this year.

Andes virus (Hantavirus)

Geographical risk areas	Chile and southern Argentina.
Sources and routes of infection	• rodent contact (excreta, or materials contaminated with excreta from an infected rodent) • person-to-person transmission described in household and hospital contacts
UK experience to date	No known cases in the UK.
Risk rating	Very low – rare cases in travellers have been reported.
Recent cases or outbreaks	No reports of hantavirus infection caused by Andes virus were identified in August 2023. However, a case in which the type of hantavirus was not specified was reported from the Andes virus risk area of Chile. On 11 August 2023, media reported a case of hantavirus in a male aged 11 years in La Araucanía; this region has reported a total of 6 cases of hantavirus in 2023.

Avian influenza A(H5N6) virus

Geographical risk areas	Mostly China. New strain reported in Greece in March 2017, and subsequently found in Western Europe in birds.
Sources and routes of infection	Close contact with infected birds or their environments.
UK experience to date	No known cases in the UK.
Risk rating	Very low – not known to have occurred in travellers (UKHSA risk assessment).
Recent cases or outbreaks	In China, 2 new cases of avian influenza A(H5N6) were reported during August 2023. The first case was reported on 17 August 2023 in Chongqing Municipality; the individual had contact with dead poultry prior to symptom onset. The second case was reported on 23 August 2023, in a female aged 27 years from Sichuan Province; no details on the potential source of infection were provided in the report. From 2014 to 23 August 2023, 86 human cases of avian influenza A(H5N6) were reported by mainland China health authorities.

Avian influenza A(H7N7) virus

Geographical risk areas	Sporadic occurrence in birds across mainland Europe and the UK. A human case was reported in Ireland in 1996, 89 cases were reported in the Netherlands in 2003, and 3 human cases were reported in Italy in 2013.
Sources and routes of infection	• close contact with infected birds or their environments • close contact with infected humans (no sustained human-to-human transmission reported)
UK experience to date	No known cases in the UK.
Risk rating	Very low – human cases are rare, and severe disease even rarer.
Recent cases or outbreaks	No reports of confirmed or suspected human cases were identified in August 2023.

Authors of this report

Emerging Infections and Zoonoses Team, UKHSA